Skip to the rundown
GetYourBrief
Search

Company · in the news since March 22, 2026

Revolution Medicines news

Revolution Medicines appeared in 6 news events on GetYourBrief between March 22, 2026 and November 9, 2026, on the Biotech and Healthcare desks. The latest: "Daraxonrasib receives FDA approval" (November 8, 2026).

When was Revolution Medicines in the news?

News events naming Revolution Medicines per month (one per story, however many outlets carried it). Source: GetYourBrief's record of the outlets' reports. April 2026 and May 2026: the intake of reports was interrupted, so these months undercount; October 2026 is in progress.

The latest news about Revolution Medicines

  1. Nov 8 · Biotech Daraxonrasib receives FDA approval 1
  2. Oct 23 · Biotech Tango shares fall 16% after 82% response rate readout at ESMO 2
  3. Aug 26 · Biotech FDA approves daraxonrasib for advanced pancreatic cancer 2
  4. Jul 6 · Biotech Moderna, Revolution Medicines, Axsome beat S&P 500 in first half, Motley Fool reports 2
  5. Mar 22 · Healthcare Dafna Capital trims Axogen stake by 265,456 shares, SEC filing shows 1

Which desks cover Revolution Medicines?

  1. Biotech 5
  2. Healthcare 1

Which outlets cover Revolution Medicines most?

  1. fool.com 3

Counted over the latest 6 events; one per outlet per event. Source: the reports linked on each event.

Who appears in the news with Revolution Medicines?

  1. Food and Drug Administration 3
  2. daraxonrasib 3
  3. RMC-6236 2

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).